Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial

INTRODUCTION: The efficacy of a cholinesterase inhibitor, donepezil, in patients with dementia with Lewy bodies (DLB) was investigated to confirm the superiority over placebo in the 12-week, double-blind phase of this phase III study. METHODS: Patients with probable DLB (n = 142) were randomly assig...

Full description

Saved in:
Bibliographic Details
Published in:Alzheimers Res Ther
Main Authors: Ikeda, Manabu, Mori, Etsuro, Matsuo, Kazutaka, Nakagawa, Masaki, Kosaka, Kenji
Format: Artigo
Language:Inglês
Published: BioMed Central 2015
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4338565/
https://ncbi.nlm.nih.gov/pubmed/25713599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-014-0083-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items